Scaling Up SPPS: Choosing the Right Thermal Technology

Temperature Control in SPPS Scale-Up

Temperature has long been recognized as a critical process parameter in Solid-Phase Peptide Synthesis (SPPS). Modern knowledge has considered applying heat during coupling and deprotection steps to speed reaction rates and reduce step-by-step cycle times. However, the value of heat at the pilot and commercial scale synthesis is not in speed, but instead drastically improving crude purity and yield. The benefits of heat are time-sensitive; extended exposure accelerates undesired reactions, particularly racemization. Achieving high crude purity and short cycle times requires precisely targeted heat delivery that drives kinetics without compromising sequence integrity.

When a therapeutic peptide moves from the research bench into pilot and commercial manufacturing, the priorities change significantly. At research scale, the priority is often simply synthesizing the target peptide. At production scales where a single batch can cost upwards of $100k of raw material and carries significant GMP related overhead, crude purity, yield, and process consistency become the critical drivers. Temperature control therefore becomes a key factor to improve crude purity, yield, reduce material loss, and minimize downstream purification burden. These considerations begin during process development at the pilot scale where process robustness, hardware scalability, supply chain predictability, and Process Mass Intensity (PMI) dictate whether a synthesis is commercially viable.

Successful peptide manufacturing requires evaluating solid-phase peptide synthesis (SPPS) parameters through the lens of industrial scale-up at the beginning of process development.

Controlled Heating to Improve Purity and Yield

Across multiple difficult model peptides, precisely controlled heating produced substantial improvements in synthesis quality. Bradykinin crude purity increased from 70% to 85%, Oxytocin from 55% to 72%, and the ABRF-1992 peptide from 63% to 78% when elevated-temperature protocols were applied. For Bivalirudin, a 60-minute coupling at 30 °C produced 60% crude purity, while a 5-minute coupling at 90 °C produced 70% crude purity.

Critically, these results also demonstrate that more heat is not necessarily better. For the difficult Jung-Redemann decapeptide, increasing the temperature from 23 °C to 60 °C improved crude purity from 13% to 39%. Yet holding the synthesis at 80 °C for the same 60-minute coupling period reduced purity to 15% as oxidation and other side products increased. At the same 80 °C temperature, shortening the coupling to just 10 minutes produced the highest crude purity at 48%. Temperature and exposure time therefore function as a coupled process parameter: sufficient heat can drive difficult reactions toward completion, while excessive thermal exposure can rapidly shift the chemistry toward unwanted side reactions.

Continue reading for a comparison of conduction, microwave, and induction heating, plus in-line solvent pre-heating, real-time temperature feedback, and considerations for pilot and commercial scale-up.

Download the full 7 page article here: Download Link

About CSBio: For over 30 years, CSBio, a leading peptide and peptide synthesizer manufacturing company located in Silicon Valley, California, has been providing cGMP peptides and automated peptide synthesizers to the global pharmaceutical community. CSBio's peptide products and peptide synthesizers can be found in production laboratories, universities, and pharmaceutical companies worldwide.